
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc has demonstrated resilience and growth potential in the behavioral healthcare sector, as evidenced by a 3% year-over-year increase in same-store admissions despite softer patient days, indicating effective management strategies. The company anticipates a significant increase in net PLGL liability on its balance sheet, suggesting a proactive approach to managing financial obligations, while also capitalizing on strong demand through organic growth initiatives, including bed expansions and new facility developments. Additionally, a planned reduction in capital expenditures by $300 million in 2026 is expected to enhance cash flow, providing the company with the financial flexibility to pursue mergers and acquisitions to further bolster its market presence.
Bears say
Acadia Healthcare Co Inc has revised its full-year 2025 guidance downward by $32.5 million, reflecting anticipated volume softness, rate pressure, and higher-than-expected PLGL expenses, which are expected to persist through 2026. The company now projects adjusted EBITDA for 2025 to be between $650-660 million, a significant reduction from the original estimate of $675-700 million, indicating a cumulative decline of approximately 13.4% since the initial guidance. Additionally, the company's adjusted EBITDA estimates for 2026 have been lowered further to $664.6 million, driven by ongoing reimbursement challenges and operational pressures, posing substantial risks to future financial performance.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares